Marijuana Penny Stocks to Watch This Week as U.S. Industry Eyes $50 Billion Growth
The U.S. cannabis industry continues to grow rapidly. In 2024, sales exceeded $33 billion, and analysts expect annual revenues to reach $50 billion by 2030. This sharp growth highlights strong consumer demand and expanding legalization trends. Recently, headlines from Washington have pointed to renewed discussion around federal reform. Specifically, lawmakers have revisited the rescheduling of cannabis, which could boost investment confidence across the market. At the same time, penny stocks remain volatile yet attractive to traders seeking high returns. Many of these companies operate in early growth phases, making them appealing short-term plays. Therefore, investors must remain disciplined and attentive to market signals.
When analyzing marijuana penny stocks, technical analysis is essential. Charting support and resistance levels provides insight into potential entry and exit points. Additionally, monitoring moving averages helps identify shifts in momentum. However, risk management should always be prioritized, especially in such a volatile sector. Traders should establish stop-loss levels before entering any trade. Position sizing is equally important to protect portfolios against sudden drawdowns. Moreover, diversification across several names can reduce overall exposure to risk. Because penny stocks often react sharply to news, traders must also monitor market headlines. As legalization advances, opportunities are likely to increase. Yet, discipline and proper planning remain crucial for success when trading cannabis penny stocks this week.
[Read More] Pot Stocks On The Rise With Potential Cannabis Rescheduling In 2025
Top Marijuana Stocks to Watch in September 2025
- Cansortium Inc. (OTC: CNTMF)
- Glass House Brands Inc. (OTC: GLASF)
- Ascend Wellness Holdings, Inc. (OTC: AAWH)
Cansortium Inc. (CNTMF)
Cansortium Inc. is a vertically integrated cannabis company headquartered in Florida. It operates under the Fluent brand, which has become widely recognized across the state. Florida represents its largest market, where it has steadily built a strong dispensary footprint. As of mid-2025, Cansortium operates over 36 dispensaries in Florida alone. Additionally, it maintains operations in Texas, Pennsylvania, and Michigan. This expansion has allowed the company to diversify revenues while keeping Florida as its primary focus. Furthermore, Cansortium emphasizes quality and consistency through its branded flower, concentrates, and edibles. The company has gained loyal medical patients in Florida due to strong product recognition. Importantly, with Florida medical sales expanding and recreational legalization discussions ongoing, the company could benefit from a potential surge in future demand. Consequently, Cansortium remains one of the most influential cannabis operators in the Florida market.
Financial Performance
Cansortium has continued to grow revenues, largely driven by its Florida market strength. In its most recent quarterly filing, revenue reached approximately $26 million, representing a year-over-year increase of nearly 11 percent. The growth was supported by consistent patient demand and improved cultivation yields. Furthermore, adjusted EBITDA came in strong, totaling $9 million, which showed improved operational efficiency. However, net income was still pressured by costs, leaving the company near break-even levels. Management has focused on cutting expenses, refinancing debt, and improving gross margins. Importantly, the company has reduced its outstanding debt balance, enhancing financial flexibility moving forward. Florida’s potential recreational cannabis vote in 2026 presents significant upside for Cansortium. With its established dispensary network, Cansortium is well-positioned to capitalize on new demand. Overall, the company’s financial results indicate progress toward stability, while leaving investors optimistic about future profitability. Consequently, CNTMF deserves attention in September 2025.
[Read More] These 2 Marijuana Stocks Could Soon Bounce In The Cannabis Sector
Glass House Brands Inc. (GLASF)
Glass House Brands is a California-based cannabis operator recognized for its large cultivation facilities. The company has invested heavily in building one of the world’s largest cannabis greenhouses. Its largest footprint is in California, where it has continued to expand its retail operations. Glass House currently operates over 15 dispensaries, primarily in Southern California. These include locations under the Glass House Farms brand and its acquisition of retail stores like The Pottery. Furthermore, the company emphasizes environmentally sustainable cultivation practices. By leveraging its large greenhouse facility, Glass House achieves significant production scale and cost efficiencies. Additionally, the company has expanded wholesale distribution, allowing its products to reach numerous third-party retailers. Consequently, Glass House has become one of the most recognized vertically integrated operators in California. Its focus on large-scale production positions it to benefit if California stabilizes its regulatory and tax environment in the coming years.
Financial Performance
Glass House recently reported strong financial momentum driven by expanding cultivation and improving wholesale pricing. Quarterly revenue came in at $48 million, representing over 20 percent year-over-year growth. Importantly, gross profit margins have improved, thanks to lower cultivation costs at its large greenhouse. Adjusted EBITDA was $11 million, showing a marked improvement from the prior year’s near break-even results. However, net income remains negative due to debt expenses and continuing operational investments. The company also reduced cash burn, which reflects tighter cost control. Additionally, Glass House continues expanding branded product penetration in California. Its flower, pre-rolls, and concentrates are gaining market share. This wholesale growth strategy could pay off if consumer demand strengthens. Despite persistent regulatory hurdles in California, Glass House has managed to outperform many smaller operators. Therefore, with growing scale and improving efficiency, GLASF remains an important marijuana stock to monitor during September 2025.
[Read More] Best Ancillary Marijuana Stocks for Investors This Week: REITs and Financing Leaders
Ascend Wellness Holdings, Inc. (AAWH)
Ascend Wellness Holdings, also known as Ascend, is a multi-state operator with a strong presence across the U.S. The company operates primarily in Northeast and Midwest markets, with its largest footprint in Illinois. Ascend currently manages 37 dispensaries across Illinois, Massachusetts, Michigan, Ohio, Pennsylvania, and New Jersey. Its largest cluster of operations is in Illinois, which has become one of the most profitable cannabis markets. Additionally, Ascend continues to build vertically integrated assets, including cultivation and processing facilities. The company focuses on branded products such as Simply Herb and Ozone, which are distributed through its retail stores. Ascend also prioritizes expansion in New Jersey and Pennsylvania, both growing medical and recreational markets. With this regional presence, Ascend has become one of the most significant East Coast operators. Consequently, the company’s position offers exposure to strong cannabis demand in states with established adult-use markets.
Financial Performance
In its latest quarterly update, Ascend Wellness reported revenue of approximately $140 million, reflecting strong year-over-year growth of 12 percent. This expansion was supported by new store openings and improved wholesale distribution. Importantly, adjusted EBITDA was reported at $30 million, showing clear operational strength. Despite the solid top-line performance, net income remains negative due to interest expenses and ongoing investments. However, management has reduced operating costs, improving gross margin compared with prior quarters. Additionally, Ascend has successfully refinanced certain debt maturities, extending its liquidity runway. The company is also heavily focused on building market share in New Jersey, which continues to expand its recreational program. Consequently, Ascend is well-positioned for long-term revenue growth. Investors should note that while profitability challenges remain, the company’s scale and footprint create significant potential. Therefore, AAWH represents a compelling cannabis stock to watch in September 2025.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
